About us

The history behind PainDrainer

The year was 2018 and Professor Carl Borrebaeck worked together with Doctor Maria Rosén Klement at Lund University in Sweden.

Maria, who herself lives with chronic pain, attended one of many programs in chronic pain rehabilitation. During the program, Maria realized that everyone who attended the program had the same problem. Every day is different, and the level of pain is affected by sleep and the many activities one is doing during the day. She realized that the pain is affected by far more parameters than the human brain can keep track of.

Maria shared her thoughts with Prof. Carl Borrebaeck, the difficulty of keeping track of the parameters affecting her pain and that advanced calculations should be able to calculate this. At this point, Maria and Carl decided to involve the IT specialist Göran Barkfors and together they began to explore the possibility of helping people with chronic pain understand their pain and thus being able to increase their quality of life through machine learning, i.e. artificial intelligence.

The goal was to create a tool that helps people with chronic, non-malignant pain to understand how different activities, and combinations of activities affect their pain level. With the aim to take control of their pain.

In the spring of 2021, PainDrainer’s pilot study was completed with very promising results. The chronic pain patients who participated in the study experienced increased quality of life and reduced pain level already after 6 weeks of using PainDrainer.

The dream came through thanks to investors, pain management specialists and chronic pain patients who, just like Maria, Carl and Göran, wholeheartedly believes in the idea, that it can help millions of chronic pain patients to live a more fulfilled life and that it can be realized.

Se filmen hur idén till PainDrainer föddes

Watch the story behind PainDrainer

Newsroom

Follow the latest new from PainDrainer.

Click here to see all the news.

Advisory Board

“I see hundreds of chronic pain patients every week and having a tool that could improve their quality of life and also help me to be more efficient and see even more patients, would be a dream."

Neel Mehta

Medical Director, Pain Management Weill Cornell Medicine NewYork-Presbyterian Hospital

"PainDrainer represents an entirely new and exciting concept in the drug-free self-management of chronic pain, due to its advanced artificial intelligence engine.”

Christer Carlsson

Medicine Doctor and Pain Management Specialist

THIS IS THE TEAM BEHIND PAINDRAINER

Our board

Carl Borrebaeck

Chairman of the board

Professor Carl Borrebaeck, is a company builder who previously founded the Nasdaq listed companies Immunovia AB, Senzagen AB, BioInvent Int. AB, and Alligator BioScience AB. Carl Borrebaeck has been awarded a number of awards, such as AkzoNobel’s Science Prize (2009); Royal Engineering Academy Gold Medal (2012) for “his ground-breaking research on biomarkers” and he was appointed the Biotech Builder of the year 2017 for his entrepreneurship. He is the Director of CREATE Health Strategic Center for Translational Cancer Research, a permanent member of the Royal Academy of Engineering Sciences, and former vice president of Lund University. Carl Borrebaeck is also the Founding Mentor for Nordic Mentor Network for Entrepreneurship (NOME). Current appointments: Chairman of PainDrainer AB, SenzaGen AB, Immunovia AB and CB Ocean Capital AB. Board member of Alligator Bioscience AB, Qlucore AB and Scandion A/S.